* WELL Health Technologies Corp WELL.TO is expected
to show a
rise in quarterly revenue when it reports results on May 9
(estimated).
* The Vancouver British Columbia-based company is expected
to
report a 26.0% increase in revenue to C$159.384 million from
C$126.51 million a year ago, according to the mean estimate from
14 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for WELL Health
Technologies
Corp is for a loss of 1 cent per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 10.0%
in the last three months.
* Wall Street's median 12-month price target for WELL Health
Technologies Corp is C$7.75, above its last closing price
of C$5.75.
Previous quarterly performance (using preferred earnings measure
in Canadian dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.02 0.09 Beat 509.1
Sep. 30 2022 -0.01 0.01 -0.02 Missed -333.4
Jun. 30 2022 0.00 0.01 -0.03 Missed -475
Mar. 31 2022 -0.01 -0.01 -0.04 Missed -200.1
Dec. -0.03 -0.03 -0.04 Missed -56.5
31 2021
Sep. 30 2021 -0.01 0.00 -0.06 Missed -1,100
Jun. 30 2021 -0.02 -0.02 -0.08 Missed -414.1
Mar. 31 2021 -0.02 -0.02 -0.04 Missed -128.6
This summary was machine generated May 5 at 14:33 GMT. All
figures in Canadian dollars unless otherwise stated